References
- A. Samaro, P. Janssens, V. Vanhoorne, J. van Renterghem, M. Eeckhout, L. Cardon, T. de Beer and C. Vervaet, Screening of pharmaceutical polymers for extrusion-based additive manufacturing of patient-tailored tablets, Int. J. Pharm. 586 (2020) 1–11; https://doi.org/10.1016/j.ijpharm.2020.119591
- J. Zhang, X. Feng, H. Patil, R. V. Tiwari and M. A. Repka, Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets, Int. J. Pharm. 519(1-2) (2017) 186–197; https://doi.org/10.1016/j.ijpharm.2016.12.049
- N. G. Solanki, M. Tahsin, A. V. Shah and A. T. M. Serajuddin, Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: Screening polymers for drug release, drug-polymer miscibility and printability, J. Pharm. Sci. 107(1) (2018) 390–401; https://doi.org/10.1016/j.xphs.2017.10.021
- A. Melocchi, F. Parietti, A. Maroni, A. Foppoli, A. Gazzaniga and L. Zema, Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling, Int. J. Pharm. 509(1-2) (2016) 255–263; https://doi.org/10.1016/j.ijpharm.2016.05.036
- E. Fuenmayor, M. Forde, A. V. Healy, D. M. Devine, J. G. Lyons, C. McConville and I. Major, Material considerations for fused-filament fabrication of solid dosage forms, Pharmaceutics 10(2) (2018) 1–27; https://doi.org/10.3390/pharmaceutics10020044
- K. Ilyés, N. K. Kovács, A. Balogh, E. Borbás, B. Farkas, T. Casian, G. Marosi, I. Tomuță and Z. K. Nagy, The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation, Eur. J. Pharm. Sci. 129(1) (2019) 110–123; https://doi.org/10.1016/j.ejps.2018.12.019
- J. Aho, J. P. Bøtker, N. Genina, M. Edinger, L. Arnfast and J. Rantanen, Roadmap to 3D-printed oral pharmaceutical dosage forms: Feedstock filament properties and characterization for fused deposition modeling, J. Pharm. Sci. 108(1) (2019) 26–35; https://doi.org/10.1016/j.xphs.2018.11.012
- C. Korte and J. Quodbach, 3D-printed network structures as controlled-release drug delivery systems: Dose adjustment, API release analysis and prediction, AAPS PharmSciTech. 19(8) (2018) 3333–3342; https://doi.org/10.1208/s12249-018-1017-0
- Q. Li, H. Wen, D. Jia, X. Guan, H. Pan, Y. Yang, S. Yu, Z. Zhu, R. Xiang and W. Pan, Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing, Int. J. Pharm. 525(1) (2017) 5–11; https://doi.org/10.1016/j.ijpharm.2017.03.066
- C. I. Gioumouxouzis, A. Baklavaridis, O. L. Katsamenis, C. K. Markopoulou, N. Bouropoulos, D. Tzetzis and D. G. Fatouros, A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery, Eur. J. Pharm. Sci. 120 (2018) 40–52; https://doi.org/10.1016/j.ejps.2018.04.020
- B. Arafat, M. Wojsz, A. Isreb, R. T. Forbes, M. Isreb, W. Ahmed, T. Arafat and M. A. Alhnan, Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets, Eur. J. Pharm. Sci. 118 (2018) 191–199; https://doi.org/10.1016/j.ejps.2018.03.019
- A. Goyanes, P. Robles Martinez, A. Buanz, A. W. Basit and S. Gaisford, Effect of geometry on drug release from 3D printed tablets, Int. J. Pharm. 494(2) (2015) 657–663; https://doi.org/10.1016/j.ijpharm.2015.04.069
- D. Chen, X. Y. Xu, R. Li, G. A. Zang, Y. Zhang, M. R. Wang, M. F. Xiong, J. R. Xu, T. Wang, H. Fu, Q. Hu, B. Wu, G. R. Yan and T. Y. Fan, Preparation and in vitro evaluation of FDM 3D-printed ellipsoid-shaped gastric floating tablets with low infill percentages, AAPS PharmSciTech. 21(1) (2020) 1–13; https://doi.org/10.1208/s12249-019-1521-x
- F. Baumann, H. Bugdayci, J. Grunert, F. Keller and D. Roller, Influence of slicing tools on quality of 3D printed parts, Comput. Aided Des. Appl. 13(1) (2016) 14–31; https://doi.org/10.1080/16864360.2015.1059184
- T. Feuerbach, S. Kock and M. Thommes, Slicing parameter optimization for 3D printing of bio-degradable drug-eluting tracheal stents, Pharm. Dev. Technol. 25(6) (2020) 650–658; https://doi.org/10.1080/10837450.2020.1727921
- T. Feuerbach, S. Kock and M. Thommes, Characterisation of fused deposition modeling 3D printers for pharmaceutical and medical applications, Pharm. Dev. Technol. 23(10) (2018) 1136–1145; https://doi.org/10.1080/10837450.2018.1492618
- J. Go, S. N. Schiffres, A. G. Stevens and A. J. Hart, Rate limits of additive manufacturing by fused filament fabrication and guidelines for high-throughput system design, Addit. Manuf. 16 (2017) 1–11; https://doi.org/10.1016/j.addma.2017.03.007
- R. Jerez-Mesa, G. Gomez-Gras, J. A. Travieso-Rodriguez and V. Garcia-Plana, A comparative study of the thermal behavior of three different 3D printer liquefiers, Mechatronics 56 (2018) 297–305; https://doi.org/10.1016/j.mechatronics.2017.06.008
- G. Verstraete, A. Samaro, W. Grymonpré, V. Vanhoorne, B. van Snick, M. N. Boone, T. Hellemans, L. van Hoorebeke, J. P. Remon and C. Vervaet, 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes, Int. J. Pharm. 536(1) (2018) 318–325; https://doi.org/10.1016/j.ijpharm.2017.12.002
- S. Palekar, P. K. Nukala, S. M. Mishra, T. Kipping and K. Patel, Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen, Int. J. Pharm. 556 (2019) 106–116; https://doi.org/10.1016/j.ijpharm.2018.11.062
- E. Fuenmayor, M. Forde, A. V. Healy, D. M. Devine, J. G. Lyons, C. McConville and I. Major, Comparison of fused-filament fabrication to direct compression and injection molding in the manufacture of oral tablets, Int. J. Pharm. 558 (2019) 328–340; https://doi.org/10.1016/j.ijpharm.2019.01.013
- A. Goyanes, F. Fina, A. Martorana, D. Sedough, S. Gaisford and A. W. Basit, Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing, Int. J. Pharm. 527(1-2) (2017) 21–30; https://doi.org/10.1016/j.ijpharm.2017.05.021
- Y. Yang, H. Wang, H. Li, Z. Ou and G. Yang, 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release, Eur. J. Pharm. Sci. 115 (2018) 11–18; https://doi.org/10.1016/j.ejps.2018.01.005
- H. Kadry, T. A. Al-Hilal, A. Keshavarz, F. Alam, C. Xu, A. Joy and F. Ahsan, Multi-purposable fila ments of HPMC for 3D printing of medications with tailored drug release and timed-absorption, Int. J. Pharm. 544(1) (2018) 285–296; https://doi.org/10.1016/j.ijpharm.2018.04.010
- P. K. Nukala, S. Palekar, N. Solanki, Y. Fu, M. Patki, A. A. Shohatee, L. Trombetta and K. Patel, Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms, 3D Print. Med. 3(1) (2019) 23–37; https://doi.org/10.2217/3dp-2018-0028
- K. Pietrzak, A. Isreb and M. A. Alhnan, A flexible-dose dispenser for immediate and extended release 3D printed tablets, Eur. J. Pharm. Biopharm. 96 (2015) 380–387; https://doi.org/10.1016/j.ejpb.2015.07.027
- E. Carlier, S. Marquette, C. Peerboom, L. Denis, S. Benali, J. M. Raquez, K. Amighi and J. Goole, Investigation of the parameters used in fused deposition modeling of poly(lactic acid) to optimize 3D printing sessions, Int. J. Pharm. 565 (2019) 367–377; https://doi.org/10.1016/j.ijpharm.2019.05.008
- Y. Joo, I. Shin, G. Ham, S. M. Abuzar, S. M. Hyun and S. J. Hwang, The advent of a novel manufacturing technology in pharmaceutics: superiority of fused deposition modeling 3D printer, J. Pharm. Investig. 50 (2020) 131–145; https://doi.org/10.1007/s40005-019-00451-1
- M. Alhijjaj, J. Nasereddin, P. Belton and S. Qi, Impact of processing parameters on the quality of pharmaceutical solid dosage forms produced by fused deposition modeling (FDM), Pharmaceutics 11(12) (2019) 1–21; https://doi.org/10.3390/pharmaceutics11120633
- J. Zhang, W. Yang, A. Q. Vo, X. Feng, X. Ye, D. W. Kim and M. A. Repka, Hydroxypropyl methyl-cellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation, Carbohydr. Polym. 177 (2017) 49–57; https://doi.org/10.1016/j.carbpol.2017.08.058
- M. Tidau, A. Kwade and J. H. Finke, Influence of high, disperse api load on properties along the fused-layer modeling process chain of solid dosage forms, Pharmaceutics 11(4) (2019) 1–17; https://doi.org/10.3390/pharmaceutics11040194
- W. Kempin, V. Domsta, G. Grathoff, I. Brecht, B. Semmling, S. Tillmann, W. Weitschies and A. Seidlitz, Immediate release 3D-printed tablets produced via fused deposition modeling of a thermo-sensitive Drug, Pharm. Res. 35(6) (2018) 1–12; https://doi.org/10.1007/s11095-018-2405-6
- C. Wei, N. G. Solanki, J. M. Vasoya, A. V. Shah and A. T. M. Serajuddin, Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release, J. Pharm. Sci. 109(4) (2020) 1558–1572; https://doi.org/10.1016/j.xphs.2020.01.015
- D. K. Tan, M. Maniruzzaman and A. Nokhodchi, Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery, Pharmaceutics 10(4) (2018) 1–23; 10.3390/pharmaceutics10040203